Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.31 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.31 |
| ▸ | GPR3 | P46089 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20062653 | 0.98 | ALDH1A1 (0.40) | ALDH1A1DUSP3KDM4EATML3MBTL1 | |
| SCHEMBL20062650 | 0.98 | ALDH1A1 (0.40) | ALDH1A1DUSP3KDM4EATML3MBTL1 | |
| SCHEMBL20062806 | 0.98 | ALDH1A1 (0.40) | ALDH1A1DUSP3KDM4EATML3MBTL1 | |
| SCHEMBL20062652 | 0.98 | ALDH1A1 (0.40) | ALDH1A1DUSP3KDM4EATML3MBTL1 | |
| SCHEMBL20062667 | 0.97 | ALDH1A1 (0.41) | ALDH1A1DUSP3KDM4EATML3MBTL1 | |
| SCHEMBL20062832 | 0.97 | ALDH1A1 (0.41) | ALDH1A1DUSP3KDM4EATML3MBTL1 | |
| SCHEMBL20062805 | 0.90 | KDM4E (0.37) | ALDH1A1DUSP3KDM4EATML3MBTL1 | |
| SCHEMBL20062662 | 0.90 | KDM4E (0.39) | ALDH1A1DUSP3KDM4EATML3MBTL1 | |
| SCHEMBL20062660 | 0.90 | KDM4E (0.39) | ALDH1A1DUSP3KDM4EATML3MBTL1 | |
| SCHEMBL20062668 | 0.90 | KDM4E (0.39) | ALDH1A1DUSP3KDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10608185-B2 | Organic electroluminescent materials and devices | UNIVERAL DISPLAY CORPORATION (US) | 2020-03-31 | — | — | US | disclosed |
| US-20180108844-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2018-04-19 | — | — | US | disclosed |
| US-20180108844-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2018-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180108844-A1 | Organic Electroluminescent Materials and Devices | SLCO4C1, SLCO2A1, SLCO2B1 | ALDH1A1 1333/4885DUSP3 4268/4885KDM4E 4299/4885 |
| US-10608185-B2 | Organic electroluminescent materials and devices | SLCO4C1, SLCO2A1, SLCO2B1 | ALDH1A1 1333/4885DUSP3 4268/4885KDM4E 4299/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.